These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Long-term therapy with beta-2 mimetics: role of tachyphylaxis]. Clauzel AM; Michel FB Allerg Immunol (Paris); 1988 Oct; 20(8):298, 301, 303-5. PubMed ID: 2903750 [TBL] [Abstract][Full Text] [Related]
23. [Variety of pharmacological action of beta agonists]. Takahashi S; Kokubu F; Adachi M Arerugi; 1992 May; 41(5):557-62. PubMed ID: 1355646 [No Abstract] [Full Text] [Related]
24. [Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?]. Virchow C Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S376-80. PubMed ID: 19941240 [No Abstract] [Full Text] [Related]
25. Inhaled beta-agonist use and life-threatening asthma. Newcomb RW Am J Respir Crit Care Med; 1995 Jul; 152(1):414. PubMed ID: 7599860 [No Abstract] [Full Text] [Related]
26. Beta-adrenergic agonist toxicity. Less of a problem, more of a perception. Ziment I Chest; 1993 May; 103(5):1591-7; discussion 1597-8. PubMed ID: 8097993 [No Abstract] [Full Text] [Related]
27. [Adrenergic broncholytic agents. Different causes and symptoms of adverse effects]. Vale JR Tidsskr Nor Laegeforen; 1972 Dec; 92(35):2442-3. PubMed ID: 4144336 [No Abstract] [Full Text] [Related]
28. Safety of long-acting beta-agonists. Mintz ML N Engl J Med; 2006 Mar; 354(11):1206-8; author reply 1206-8. PubMed ID: 16540628 [No Abstract] [Full Text] [Related]
29. [Lactic acidosis occurring after inhaled beta2 agonists during an asthma attack]. Du-Thanh A; Groleron S; Le Quellec A Rev Med Interne; 2004 Jun; 25(6):470-1. PubMed ID: 15158320 [No Abstract] [Full Text] [Related]
30. [Risk-benefit assessment and value of beta-2-sympathomimetic drugs in asthma therapy]. Schulz V; Ulmer WT; Kleinsorge H Pneumologie; 1992 Aug; 46(8):315-21. PubMed ID: 1357653 [No Abstract] [Full Text] [Related]
31. [Adrenergic beta 2-agonists are to be considered more as friends than enemies]. Löfdahl CG; Svedmyr N Lakartidningen; 1992 Aug; 89(32-33):2572-3. PubMed ID: 1354780 [No Abstract] [Full Text] [Related]
36. The FDA and safe use of long-acting beta-agonists in the treatment of asthma. Chowdhury BA; Dal Pan G N Engl J Med; 2010 Apr; 362(13):1169-71. PubMed ID: 20181964 [No Abstract] [Full Text] [Related]
37. [Beta 2 agonists and the course of bronchial asthma]. Chazan R; Droszcz W Pol Arch Med Wewn; 1992; 87(4-5):285-8. PubMed ID: 1355903 [No Abstract] [Full Text] [Related]
38. [Desensitization of beta-adrenergic receptors at the bronchopulmonary level]. Advenier C; Brion N; Matran R; Naline E; Varoquaux O; Duroux P Therapie; 1986; 41(6):455-60. PubMed ID: 2880406 [No Abstract] [Full Text] [Related]